ArticleEuropean journal of pediatrics2026
Incidental finding of esophageal eosinophilia in patients investigated for suspected celiac disease: results from a pediatric retrospective study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Incidental esophageal eosinophilia (EE) can be detected in children investigated for suspected celiac disease (CD), but the relationship between CD and eosinophilic esophagitis (EoE) remains unclear. This study describes the characteristics of these patients and evaluates whether EE resolves on a gluten-free diet (GFD). This retrospective study included all patients < 18 years biopsied for suspected CD (2018-2025). When esophageal abnormalities were observed, additional biopsies were taken. Cases (CD + EE) had positive antitransglutaminase antibodies-classified as active CD (ACD) or potential CD (PCD) if presented or not intestinal damage- and biopsy-proven EE (≥ 15 eos/HPF). Comparators were randomly selected among CD-diagnosed patients without macroscopical esophageal abnormalities (CD + EE -). Clinical, immunological, and histological features were compared. EE remission (< 15 eos/HPF) was assessed in cases after treatment. PCD patients received proton pump inhibitors (PPIs) for 8 weeks, with GFD prescribed only if PPIs failed. ACD patients received a 6-month GFD first, with PPIs added if esophageal remission was not achieved. 14/520 children (2.7%) had confirmed EE (9 ACD, 5 PCD). Only 2/14 (14%) were symptomatic. Compared to 100 CD + EE - subjects, cases were significantly more likely to be male (86% vs. 34%; p = 0.0003), atopic (57% vs. 22%; p = 0.009), and having peripheral eosinophilia (86% vs. 12%; p < 0.0001). Overall, GFD induced EE remission in 5/11 (45%) of cases. Most ACD patients required additional PPI therapy after GFD failure.
conclusionIncidental EE affects ~ 3% of pediatric CD evaluations. These patients typically fulfill histological EoE criteria and are often asymptomatic. Male sex, atopy, and peripheral eosinophilia are strongly associated to this condition. While GFD resolves EE in nearly half of cases, the persistence in others suggests EE is frequently an independent comorbidity. Nonetheless, a GFD is a viable first-line approach in dual-diagnosis patients. WHAT IS KNOWN: • Incidental esophageal eosinophilia (EE) is sometimes found in children being evaluated for celiac disease (CD). • The precise clinical relationship and overlap between celiac disease and eosinophilic esophagitis (EoE) remain unclear. WHAT IS NEW: • Incidental EE affects ~3% of pediatric CD cases; patients are often asymptomatic but strongly linked to male sex, atopy, and peripheral eosinophilia. • A gluten-free diet solves EE in aroung 45% of cases, making it a viable first-line approach in dual diagnosis of EE and celiac disease, though others additional, EE specific therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.